HHS Recovery Act Recipient Reporting Readiness Tool
Step 4. Review and Copy the Grant Awards Data
TAGGS provides some – but not all – of the data needed for the Recipient Report. Recipients are responsible for directly collecting and reporting all required data to FederalReporting.gov. Data that HHS does not currently collect are highlighted in yellow. Do not copy this highlighted information. Please enter the appropriate data for your organization in these required fields. For assistance with entering these data please contact FederalReporting.gov.
You may capture the data HHS does provide by copying data from this screen and pasting it into the reporting format of your choice, such as the Excel spreadsheet template, the XML template, or by logging into the online form. For assistance with copying and pasting these data please email our help desk at Readiness Help
Prime Recipient Report
Award Detail for: ANALYTICAL MICROTOOLS FOR DISCOVERING AUTOREACTIVE LYMPHOCYTESRecipient Name:MASSACHUSETTS INSTITUTE OF TECHNOLOGY
DUNS Number: 001425594
77 MASS AVE, BLDG E19-583
CAMBRIDGE, MA 02139
Reporting Information
Award Type*: Grant
Award Number*: 5RC1AI086152-02
Final Report*: Recipient responsible for this data
Award Recipient Information
Recipient DUNS Number*: 001425594
Recipient Account Number: Recipient responsible for this data
Recipient Congressional District*: 8
Award Information
Funding Agency Code*: 7529
Awarding Agency Code*:7529
Award Date*: 08-18-2010
Amount of Award*: $ 499,884
Program Source (TAS)*: 750845
CFDA Number*: 93.701
Sub Account Number for Program Source (TAS)*: Recipient responsible for this data
Total Number of Sub Awards to Individuals*: Recipient responsible for this data
Total Amount of Sub Awards to Individuals*: Recipient responsible for this data
Total Number of Payments to Vendors less than $25,000/award*: Recipient responsible for this data
Total Amount of Payments to Vendors less than $25,000/award*: Recipient responsible for this data
Total Number of Sub Awards less than $25,000/award*: Recipient responsible for this data
Total Amount of Sub Awards less than $25,000/award*: Recipient responsible for this data
Award Description* DESCRIPTION (provided by applicant): This application addresses broad Challenge Area (04) Clinical Research and specific Challenge Topic, 04-AR-101: Autoimmunity For Diseases Of The Skin, Joints, Muscle And Other Tissues-Develop reagents and analytic methods to identify, characterize, track, and inhibit human B and T cells specific for defined selfantigens, and antigen-presenting cells. Autoimmune diseases such as multiple sclerosis (MS), type 1 diabetes (T1D) and rheumatoid arthritis (RA) are complex genetic diseases mediated by activated, autoreactive T cells and B cells. The presence of clonally expanded populations of T cells and B cells in the inflamed tissue of patients has long suggested that self-antigens drive the disease process. A major challenge hindering the study of human autoimmune diseases is the reliable identification and characterization of autoreactive B and T cells. These rare, self-reactive cells are present in the periphery, albeit at very low frequencies (>1 in 10,000). The technologies used for studying these cells include flow cytometry and immunosorbant assays, but these methods either have insufficient sensitivity for detecting low-frequency cells or the recovery of the cells is not possible. Significant advances in the understanding of the etiologies of autoimmune diseases would be possible if it were feasible to assess the frequency, clonal variations, and functional responses of autoreactive B and T cells in these diseases directly ex vivo. The central goal of this research is to establish a novel set of methods that use microfabricated systems to isolate and detect both self-reactive B and T cells. This project involves a collaboration amongst: the Wucherpfennig lab (Dana Farber) with expertise in recombinant antigens for MS to identify B and T cells, the Hafler lab (Brigham and Women's) with expertise in cloning and characterizing autoreactive T cells in MS, and the Love lab (MIT) with expertise in simultaneous parallel analyses of secreted products from >105 single primary cells. Specifically, we will develop single-cell multiparametric assays using arrays of nanowells to recover antigen-specific B cells from pediatric and adult MS patients. In a parallel aim, we will also develop a complementary method to identify autoreactive T cells in MS patients. The microstructure common to both of these aims-the arrays of nanowells-will enable an integrated technology platform capable of comprehensive characterization of both compartments of selfreactive lymphocytes. We will use these technologies to profile B cell responses in pediatric MS patients and evaluate the frequencies and clonal diversity in self-reactive T cells from MS patients. The outcome of these studies will be specific unprecedented knowledge on the breadth of B and T cell populations in MS that has not been accessible previously, and more broadly, a general process for evaluating these types of self-reactive cells in many human autoimmune diseases. PUBLIC HEALTH RELEVANCE: Autoimmune diseases are challenging to study because the cells involved in the disease-self-reactive B and T cells-are rare. Understanding the nature and diversity of these cells involved in the progression of diseases such as multiple sclerosis and type 1diabetes would aid in the development of new therapies, but the cells are difficult to detect and isolate with existing technologies. The aim of this project is to develop new technologies based on microfabricated systems that will allow the isolation and characterization of both B and T cells relevant for autoimmune diseases, but also for other human diseases.
Project Information
Project Name or Project/Program Title*: ANALYTICAL MICROTOOLS FOR DISCOVERING AUTOREACTIVE LYMPHOCYTES
Project Status*: Recipient responsible for this data
Total Federal Amount of ARRA Funds Received/Invoiced*: Recipient responsible for this data
Number of Jobs*: Recipient responsible for this data
Description of Jobs Created*: Recipient responsible for this data
Quarterly Activities/Project Description*: Recipient responsible for this data
Activity Code (NAICS or NTEE-NPC)*: Recipient responsible for this data
Total Federal Amount of ARRA Expenditure* (Enter the cumulative total amount of Recovery Funds received that were expended to projects or activities. Refer to the Data Model for details on how to calculate this amount.): Recipient responsible for this data
Total Federal ARRA Infrastructure Expenditure Recipient responsible for this data
Infrastructure Contact Name: Recipient responsible for this data
Infrastructure Contact Email: Recipient responsible for this data
Infrastructure Contact Phone: Recipient responsible for this data
Infrastructure Contact Phone Ext: Recipient responsible for this data
Infrastructure Contact Street Address 1: 77 MASS AVE, BLDG E19-583
Infrastructure Contact Street Address 2: Not Available
Infrastructure Contact Street Address 3: Recipient responsible for this data
Infrastructure City: CAMBRIDGE
Infrastructure State: MA
Infrastructure ZIP Code+4: 02139
Infrastructure Purpose and Rationale (If applicable, enter an explanation about how the infrastructure investment will contribute to one or more purposes of the Recovery Act. Refer to the Data Model for details on what to report. 4000 characters or less.): Recipient responsible for this data
Primary Place of Performance
Street Address 1: 77 MASSACHUSETTS AVEE19-750
Street Address 2: CAMBRIDGE
City*: CAMBRIDGE
State*: MA
ZIP Code+4*: 2139
Congressional District*: 8
Country*: US
Recipient Highly Compensated Officers
Prime Recipient Indication of Reporting Applicability*: Recipient responsible for this data
- Officer Name and Compensation: Recipient responsible for this data
- Officer Name and Compensation: Recipient responsible for this data
- Officer Name and Compensation: Recipient responsible for this data
- Officer Name and Compensation: Recipient responsible for this data
- Officer Name and Compensation: Recipient responsible for this data
This concludes the current search. To begin a new search, return to the HHS Recovery Act Recipient Reporting Readiness Tool Landing Page.
Use in the Recipient Report
The information provided by this tool is baseline data that the Recipient should include in the Recipient Report that must be submitted to FederalReporting.gov beginning October 1, 2009. The data from this tool can be cut and pasted directly into the Recipient Report.







